Search | IOVS | ARVO Journals

Showing 1 – 20 of 23

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Real world evidence of retinal vein occlusion (RVO) patient treatment with ranibizumab in Germany based on the 24 months interim results of the non-interventional, observational PACIFIC study

Katrin Lorenz; Christos Haritoglou; Kristina Markova; Berenice Rösler; Matthias Iwersen; Ulrike Michel; Bianca Apitzsch; Hüsnü Berk; Christian Karl Brinkmann; Ramin Khoramnia; Martin Scheffler; Jens Schrecker; Gregor Schwert; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1310. doi:

ARVO Annual Meeting Abstract July 2019

Retreatment needs of patients with proliferative diabetic retinopathy treated with ranibizumab, laser or combination therapy

Andreas Stahl; Sandra Liakopoulos; Katrin Lorenz; Claudia Quiering; Laureen Sander; Georg Spital; Gabriele E Lang

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1734. doi:

ARVO Annual Meeting Abstract July 2019

Influence of ranibizumab, laser photocoagulation or combination therapy on high-risk proliferative diabetic retinopathy

Katrin Lorenz; Gabriele E Lang; Andreas Stahl; Claudia Quiering; Laureen Sander; Georg Spital; Sandra Liakopoulos

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2789. doi:

ARVO Annual Meeting Abstract July 2019

Observation of ranibizumab treatment in real-life conditions – an interim analysis of the myopic choroidal neovascularization (mCNV) population within the observational, non-interventional PACIFIC study

Kristina Markova; Christos Haritoglou; Matthias Iwersen; Ulrike Michel; Martina Junge; Peter Geuking; Katrin Lorenz; Thomas Ach; Ramin Khoramnia; Andreas Schmidt; Judith Becker; Erik Beeke; Mathias Müller-Holz; Daniel Barthelmes; Focke Ziemssen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4320. doi:

ARVO Annual Meeting Abstract July 2019

Presence and progression of atrophic areas in pathological myopia

Charlotte Anne Melzer; Focke Ziemssen; Nicole Eter; Christian Karl Brinkmann; Hansjürgen Agostini; Gisela Haeusser-Fruh; Uwe Rose; Marc Schargus; Katrin Lorenz; Frank G Holz; Steffen Schmitz-Valckenberg

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4352. doi:

ARVO Annual Meeting Abstract June 2017

Efficacy and Safety of Preoperative IOP Reduction better for Preservative-free Fixed Combination of Dorzolamide/timolol Eye Drops versus Oral Acetazolamide and Dexamethasone Eye Drops for Outcome of Trabeculectomy

Katrin Lorenz; Joanna Wasielica-Poslednik; Katharina Bell; Guilia Renieri; Alexander Keicher; Christian Ruckes; Norbert Pfeiffer; Hagen Thieme

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2103. doi:

ARVO Annual Meeting Abstract June 2017

Baseline parameters of the HELP study (long-term observation of Caucasians with pathologic myopia): distribution of age in pre-defined risk categories for developing a myopic choroidal neovascularization

Charlotte Melzer; Focke Ziemssen; Nicole Eter; Christian Karl Brinkmann; Hansjuergen Agostini; Gisela Haeusser-Frueh; Schargus Marc; Katrin Lorenz; Frank G Holz; Steffen Schmitz-Valckenberg

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5489. doi:

ARVO Annual Meeting Abstract June 2017

Main results of the First-In Human single ascending dose phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2) in glaucoma filtration surgery

Bogomil Voykov; Hagen Thieme; Katharina Bell; Melanie Weigel; Guilia Renieri; Barbara Wilhelm; Katrin Lorenz; Petra Fettes; Eugen Leo; Norbert Pfeiffer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5577. doi:

ARVO Annual Meeting Abstract September 2016

A phase I First-In Human single ascending dose study of ISTH0036, a potent and selective antisense oligonucleotide targeting transforming growth factor beta 2 (TGF-β2) for the treatment of primary open-angle glaucoma

Bogomil Voykov; Katrin Lorenz; Claudia Schuart; Paul Richter; Barbara Wilhelm; Lars Choritz; Verena Prokosch-Willing; Petra Fettes; Eugen Leo; Norbert Pfeiffer

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3029. doi:

ARVO Annual Meeting Abstract September 2016

Antigen-antibody interactions predict the classification and progression of glaucoma

Sarah Liebezeit; Sabine Beck; Dominik Wolters; Julia Teister; Katrin Lorenz; Norbert Pfeiffer; Franz H Grus

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3897. doi:

ARVO Annual Meeting Abstract April 2014

Relationship of intraocular pressure related patterns as determined by repeated applanation tonometry and a contact lens sensor in patients with open angle glaucoma

Christina A Korb; Rene Goedkoop; Norbert Pfeiffer; Katrin Lorenz

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):122. doi:

ARVO Annual Meeting Abstract April 2014

Analysis of the Effects of Taflotan® Sine on Tear Protein Profiles

Sebastian Funke; Katrin Lorenz; Marion Kotterer; Sabine Beck; Wolters Dominik; Norbert Pfeiffer; Franz H Grus; Experimental Ophthalmology, University Medical Center, Mainz, Germany

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1474. doi:

ARVO Annual Meeting Abstract April 2014

Catestatin-like immunoreactivity in the rat eye

Maren Kriechbaum; Oliver W Gramlich; Katrin Lorenz; Franz H Grus; Daniela Ehrlich; Christian Humpel; Reiner Fischer Colbrie; Nikolaos . E Bechrakis; Josef Troger

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1844. doi:

ARVO Annual Meeting Abstract April 2014

Evaluation of Intravitreal Aflibercept for Treatment of Diabetic Macular Edema: Visual Acuity Subgroups in VIVID-DME and VISTA-DME

Katrin Lorenz; VIVID-DME and VISTA-DME study investigators

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5054. doi:

ARVO Annual Meeting Abstract June 2013

Serum protein analysis of patients with different vitreoretinal diseases by means of antibody microarrays

Christina Korb; Sabine Beck; Katrin Lorenz; Alireza Mirshahi; Bernhard Stoffelns; Norbert Pfeiffer; Franz Grus

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3332. doi:

ARVO Annual Meeting Abstract June 2013

IgG Autoimmunity Analysis In Aqueous Humor Of Patients With Pseudoexfoliation Syndrome, Pseudoexfoliation Glaucoma and Cataract Controls

Joanna Wasielica-Poslednik; Katrin Lorenz; Marcus Schlich; Norbert Pfeiffer; Franz Grus

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):164. doi:

ARVO Annual Meeting Abstract June 2013

Intraocular pressure measured by tonometry and a contact lens sensor in patients with open angle glaucoma

Katrin Lorenz; Rene Goedkoop; Marcel Keilani; Nele Berssenbruegge; Christina Korb; Joanna Wasielica-Poslednik; Norbert Pfeiffer

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5641. doi:

ARVO Annual Meeting Abstract March 2012

IgG Subclass Autoimmunity Analysis In Sera Of Patients With Pseudoexfoliation Syndrome, Pseudoexfoliation Glaucoma and Cataract Controls

Joanna Wasielica-Poslednik; Katrin Lorenz; Marcus Schlich; Nils Boehm; Norbert Pfeiffer; Franz H. Grus

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3854. doi:

ARVO Annual Meeting Abstract March 2012

Ge-25-like Immunoreactivity In The Rat Eye

Katrin Lorenz; Oliver W. Gramlich; Franz H. Grus; Daniela Ehrlich; Christian Humpel; Josef Troger

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4918. doi:

ARVO Annual Meeting Abstract March 2012

Intraindividual Proteomic Comparison of Human Tears and Vitreous in Patients With Different Vitreoretinal Diseases by Means of Antibody Microarrays

Christina A. Korb; Nils Boehm; Sabine Beck; Johannes Hummel; Katrin Lorenz; Alireza Mirshahi; Bernhard M. Stoffelns; Norbert Pfeiffer; Franz H. Grus

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):888. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Specify Date Range

Real world evidence of retinal vein occlusion (RVO) patient treatment with ranibizumab in Germany based on the 24 months interim results of the non-interventional, observational PACIFIC study

Retreatment needs of patients with proliferative diabetic retinopathy treated with ranibizumab, laser or combination therapy

Influence of ranibizumab, laser photocoagulation or combination therapy on high-risk proliferative diabetic retinopathy

Observation of ranibizumab treatment in real-life conditions – an interim analysis of the myopic choroidal neovascularization (mCNV) population within the observational, non-interventional PACIFIC study

Presence and progression of atrophic areas in pathological myopia

Efficacy and Safety of Preoperative IOP Reduction better for Preservative-free Fixed Combination of Dorzolamide/timolol Eye Drops versus Oral Acetazolamide and Dexamethasone Eye Drops for Outcome of Trabeculectomy

Baseline parameters of the HELP study (long-term observation of Caucasians with pathologic myopia): distribution of age in pre-defined risk categories for developing a myopic choroidal neovascularization

Main results of the First-In Human single ascending dose phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2) in glaucoma filtration surgery

A phase I First-In Human single ascending dose study of ISTH0036, a potent and selective antisense oligonucleotide targeting transforming growth factor beta 2 (TGF-β2) for the treatment of primary open-angle glaucoma

Antigen-antibody interactions predict the classification and progression of glaucoma

Relationship of intraocular pressure related patterns as determined by repeated applanation tonometry and a contact lens sensor in patients with open angle glaucoma

Analysis of the Effects of Taflotan® Sine on Tear Protein Profiles

Catestatin-like immunoreactivity in the rat eye

Evaluation of Intravitreal Aflibercept for Treatment of Diabetic Macular Edema: Visual Acuity Subgroups in VIVID-DME and VISTA-DME

Serum protein analysis of patients with different vitreoretinal diseases by means of antibody microarrays

IgG Autoimmunity Analysis In Aqueous Humor Of Patients With Pseudoexfoliation Syndrome, Pseudoexfoliation Glaucoma and Cataract Controls

Intraocular pressure measured by tonometry and a contact lens sensor in patients with open angle glaucoma

IgG Subclass Autoimmunity Analysis In Sera Of Patients With Pseudoexfoliation Syndrome, Pseudoexfoliation Glaucoma and Cataract Controls

Ge-25-like Immunoreactivity In The Rat Eye

Intraindividual Proteomic Comparison of Human Tears and Vitreous in Patients With Different Vitreoretinal Diseases by Means of Antibody Microarrays

To View More...

You must be signed into an individual account to use this feature.